Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Stéphane Champiat, Lambros Tselikas, Siham Farhane, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 3, pp. 665-679
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 341
Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 137
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 2, pp. 129-143
Open Access | Times Cited: 96
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0
Egesta Lopci, Rodney J. Hicks, Antonia Dimitrakopoulou-Strauß, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2323-2341
Open Access | Times Cited: 76
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
Angela Q. Zhang, Alexander Hostetler, Laura E. Chen, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1113-1128
Open Access | Times Cited: 41
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 20
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
Raymond J. Lim, Ramin Salehi‐Rad, Linh M. Tran, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101479-101479
Open Access | Times Cited: 19
Maximizing response to intratumoral immunotherapy in mice by tuning local retention
Noor Momin, Joseph R. Palmeri, Emi A. Lutz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Hsuan‐Chen Liu, Daniel Davila Gonzalez, Dixita Viswanath, et al.
Advanced Science (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 27
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
Ilio Vitale, Takahiro Yamazaki, Erik Wennerberg, et al.
Trends in cancer (2021) Vol. 7, Iss. 6, pp. 557-572
Open Access | Times Cited: 53
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Aubin Pitiot, Nathalie Heuzé-Vourc’h, Thomas Sécher
Antibodies (2022) Vol. 11, Iss. 3, pp. 56-56
Open Access | Times Cited: 35
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
Laurent Dercle, Shawn Sun, Romain-David Seban, et al.
Radiology (2022) Vol. 306, Iss. 1, pp. 32-46
Closed Access | Times Cited: 32
A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy
Zan Dai, Qiaoyun Wang, Jie Tang, et al.
Biomaterials (2022) Vol. 284, pp. 121533-121533
Closed Access | Times Cited: 29
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 5, pp. 869-879
Open Access | Times Cited: 6
Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity
Luciano Santollani, Laura Maiorino, Yiming Zhang, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1820-1829
Open Access | Times Cited: 6
Interventional Radiology for Local Immunotherapy in Oncology
Lambros Tselikas, Stéphane Champiat, Rahul A. Sheth, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 10, pp. 2698-2705
Open Access | Times Cited: 37
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections
Aviva Levina, Debbie C. Crans, Peter A. Lay
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 790-790
Open Access | Times Cited: 27
Tumor response assessment on imaging following immunotherapy
Antonia M. Berz, Clarisse Dromain, Naïk Vietti Violi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
Emi A. Lutz, Yash Agarwal, Noor Momin, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 36
Open Access | Times Cited: 24
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes
Hsuan‐Ping Chang, Huyen Khanh Le, Dhaval K. Shah
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1132-1132
Open Access | Times Cited: 15
Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment
A. Hope, Samantha J. Wade, Morteza Aghmesheh, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 399-413
Closed Access | Times Cited: 29
Transient Lymph Node Immune Activation by Hydrolysable Polycarbonate Nanogels
Christian Czysch, Carolina Medina‐Montano, Zifu Zhong, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 35
Open Access | Times Cited: 21
A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity
Fanfei Meng, Jianping Wang, Yanying He, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 22
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top